| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/10717540600559510 |
| P698 | PubMed publication ID | 17107928 |
| P2093 | author name string | Suzanne Hermeling | |
| Prashant J Chikhale | |||
| Dennis M Killian | |||
| P2860 | cites work | Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids | Q22010207 |
| Selective expression of the large neutral amino acid transporter at the blood-brain barrier | Q24672407 | ||
| Junctions between intimately apposed cell membranes in the vertebrate brain | Q24682725 | ||
| Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier | Q28378235 | ||
| Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98) | Q28570781 | ||
| A bioreversible prodrug approach designed to shift mechanism of brain uptake for amino-acid-containing anticancer agents | Q31961736 | ||
| Modulating blood-brain barrier interactions of amino acid-based anticancer agents | Q33909624 | ||
| Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier | Q34004944 | ||
| StainingPO2 measurement sites in the rat brain cortex and quantitative morphometry of the surrounding capillaries | Q36589392 | ||
| New approaches to drug delivery through the blood-brain barrier | Q40534942 | ||
| Carrier-mediated transport of baclofen across monolayers of bovine brain endothelial cells in primary culture | Q41419038 | ||
| Drug entry into the brain | Q41729326 | ||
| Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature | Q43638378 | ||
| Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity | Q47951227 | ||
| Kinetics of neutral amino acid transport across the blood-brain barrier | Q48186517 | ||
| High levels of P-glycoprotein detected in isolated brain capillaries | Q48233025 | ||
| Diet and uptake of aldomet by the brain: competition with natural large neutral amino acids | Q48265693 | ||
| Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier | Q48328037 | ||
| Carrier-mediated transport of the antitumor agent acivicin across the blood-brain barrier. | Q49270919 | ||
| Drug metabolizing enzymes in the brain and cerebral microvessels | Q57997191 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug delivery | Q1392806 |
| P304 | page(s) | 25-31 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Drug Delivery | Q5308838 |
| P1476 | title | Targeting the cerebrovascular large neutral amino acid transporter (LAT1) isoform using a novel disulfide-based brain drug delivery system | |
| P478 | volume | 14 |
| Q57677287 | Drug transport across the blood-brain barrier |
| Q35134086 | Exoplasmic cysteine Cys384 of the HDL receptor SR-BI is critical for its sensitivity to a small-molecule inhibitor and normal lipid transport activity |
| Q30394357 | Focused ultrasound-mediated drug delivery through the blood-brain barrier |
| Q37330041 | Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity |
| Q52563214 | Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1. |
| Q94598829 | L-Type amino acid transporter 1 as a target for drug delivery |
| Q36923089 | LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs |
| Q42221833 | LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates |
| Q37995554 | Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery |
| Q38612543 | Microbubble-Assisted Ultrasound for Drug Delivery in the Brain and Central Nervous System |
| Q37855817 | Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier |
| Q37636171 | Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis |
| Q37150860 | Prodrug approaches for CNS delivery |
| Q48554104 | Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1). |
| Q90494434 | Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1) |
| Q36747640 | Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1 |
| Q99711228 | Toward a Systematic Structural and Functional Annotation of Solute Carriers Transporters-Example of the SLC6 and SLC7 Families |
Search more.